SMAD3 and brain infarction: Few studies have shown that miR-323-5p controls apoptosis in cerebral infarction conditions by modulating the transforming growth factor-β1 (TGF-β1)/Smad3 signaling pathway [15] or BRI3 [16], but no studies have been conducted regarding the mechanisms associated with DEX.